Publication & Citation Trends
Publications
0 total
Abstract 6093: IDE161, a potential first-in-class clinical candidate PARG inhibitor, selectively targets homologous-recombination-deficient and PARP inhibitor resistant breast and ovarian tumors
Cited by 12
Semantic Scholar
Abstract 2043: Synthetic lethality of PARG inhibition in tumors with homologous recombination deficiencies
Cited by 0
Semantic Scholar
Author response: KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer OA
Cited by 0
Semantic Scholar
KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer OA
Cited by 144
Semantic Scholar
Abstract B21: CRISPR screens provide a comprehensive assessment of cancer vulnerabilities but generate false-positive hits for highly amplified genomic regions
Cited by 3
Semantic Scholar
Correction: KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer OA
Cited by 16
Semantic Scholar
CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic Regions. OA
Cited by 335
Semantic Scholar
Developmental stage-specific transformation of neural progenitors OA
Cited by 1
Semantic Scholar
Research Topics
Glioma Diagnosis and Treatment
(20)
CRISPR and Genetic Engineering
(18)
Cancer, Hypoxia, and Metabolism
(9)
MicroRNA in disease regulation
(6)
Lung Cancer Treatments and Mutations
(6)
Affiliations
Novartis (Switzerland)
University Health Network
University of Toronto
York University
Toronto Western Hospital